Back
TriSalus Life Sciences, Inc. Stock Predictions
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
50
TLSI
TriSalus Life Sciences, Inc.
Last Price:
$6.72
Seasonality Move:
29.79%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiTriSalus Life Sciences, Inc. Stock Forecast
-
Over the next 52 weeks, TriSalus Life Sciences, Inc. has on average historically fallen by 11.9% based on the past 4 years of stock performance.
-
TriSalus Life Sciences, Inc. has fallen lower in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is TriSalus Life Sciences, Inc. Stock Undervalued?The current TriSalus Life Sciences, Inc. [TLSI] share price is $6.70. The Score for TLSI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
TLSI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will TriSalus Life Sciences, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, TriSalus Life Sciences, Inc. has on average historically fallen by 11.9% based on the past 4 years of stock performance.
TriSalus Life Sciences, Inc. Stock Rating
Sell
50
TriSalus Life Sciences, Inc. (TLSI)
is a Sell
Is TriSalus Life Sciences, Inc. overpriced?
-
TriSalus Life Sciences, Inc. has fallen lower in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
TriSalus Life Sciences, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
trisaluslifesci.com
52-Week Data
52-Week High:
7.32
52-Week Low:
3.42
Prediction Charts
Market Cap:
334.8M
Price in USD:
6.70
Volume:
95.5K
Beta:
1.14
Technical Analysis
SMA50:
4.97
SMA100:
4.80
SMA200:
5.08
52-Wk Change:
62.62%
Stock Predictions
-
Is TriSalus Life Sciences, Inc. stock public?Yes, TriSalus Life Sciences, Inc. is a publicly traded company.
-
What is the TriSalus Life Sciences, Inc. stock quote today?The TriSalus Life Sciences, Inc. stock price is 6.70 USD today.
-
How to buy TriSalus Life Sciences, Inc. stock online?You can buy TriSalus Life Sciences, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 4.09 | 4.56 | 4.88 | 3.79 |
| Nov-17 | 4.53 | 4.48 | 4.60 | 4.36 |
| Nov-18 | 4.50 | 4.60 | 4.64 | 4.47 |
| Nov-19 | 4.58 | 4.58 | 4.69 | 4.50 |
| Nov-20 | 4.65 | 4.96 | 5.09 | 4.57 |
| Nov-21 | 4.80 | 5.07 | 5.10 | 4.71 |
| Nov-24 | 5.07 | 5.55 | 5.95 | 4.98 |
| Nov-25 | 5.61 | 6.29 | 6.40 | 5.41 |
| Nov-26 | 6.29 | 6.47 | 6.51 | 5.97 |
| Nov-28 | 6.56 | 6.87 | 6.91 | 6.56 |
| Dec-1 | 6.76 | 7.00 | 7.32 | 6.64 |
| Dec-2 | 7.00 | 6.45 | 7.00 | 6.27 |
| Dec-3 | 6.44 | 6.43 | 6.81 | 6.06 |
| Dec-4 | 6.41 | 6.70 | 6.87 | 6.41 |
TriSalus Life Sciences, Inc. Earnings
TriSalus Life Sciences, Inc. Earnings Report: Per Share TriSalus Life Sciences, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
TriSalus Life Sciences, Inc. Forecast Revenue Growth
TriSalus Life Sciences, Inc. Stock Analysis: Historical quarterly revenues per share for TriSalus Life Sciences, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.29 per share.
* TriSalus Life Sciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.